Results 121 to 130 of about 44,074,051 (232)

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Programa de fertilización sustentable para plantaciones de cítricos en Tabasco, México / Sustainable fertilization program for plantations of citrus in Tabasco, Mexico

open access: yesEcosistemas y Recursos Agropecuarios, 2016
Se utilizó el Sistema Integrado para Recomendar Dosis de Fertilización (SIRDF) para generar un programa de fertilización sustentable en plantaciones de cítricos de la Sabana de Huimanguilo, Tabasco, México.
Sergio Salgado-García   +11 more
doaj  

The microbiome in human skin aging

open access: yesFEBS Letters, EarlyView.
Age‐related skin changes encompass the well‐known visible phenotypic alterations, together with microbiome dysbiosis and a series of molecular aging hallmarks. These hallmarks characterize not only a fully stablished aged phenotype but also the skin aging process itself.
Manuel Huerta Arana   +3 more
wiley   +1 more source

Phosphate additive modification of C–S–H and C–A–S–H crystallization pathways

open access: yes
Phosphate-based additives are commonly used in concrete technology as hydration retarders and dispersion enhancers, playing a critical role in controlling cement hydration kinetics.
Ladner, Luca   +4 more
core   +1 more source

Autophagy and mitophagy in pancreatic β‐cell homeostasis and their involvement in diabetes pathophysiology

open access: yesFEBS Letters, EarlyView.
This review focuses on the role of autophagy and mitophagy in maintaining pancreatic β‐cell function and homeostasis. We discuss how genetic defects affecting these pathways contribute to the development of type 1, type 2, monogenic, and gestational diabetes. We further explore their potential as therapeutic targets. Created in BioRender.
Yunkyeong Lee   +2 more
wiley   +1 more source

Envelope addressed to S. B. Simmons from C. H. Carroll

open access: yes, 1930
Envelope addressed to S. B. Simmons from C. H. Carroll. R. W.
Carroll, C. H.
core  

Partial depletion of plasminogen activator inhibitor‐1 decreases subcutaneous fat cell hypertrophy and liver cholesterol in high‐fat‐fed female mice

open access: yesFEBS Letters, EarlyView.
Obesity raises blood levels of PAI‐1, a protein linked to metabolic dysfunction‐associated steatotic liver disease in people with obesity. In female mice fed a high‐fat diet, partially lowering PAI‐1 led to smaller subcutaneous fat cells and lower liver cholesterol, without changing body weight or insulin sensitivity.
Claudia E. Ramirez Bustamante   +10 more
wiley   +1 more source

Large-bite bisphosphite, 1,3-C(6)H(4){OPOC(10)H(6)(mu-S)C(10)H(6)O}(2): Synthesis, copper(I), and gold(I) complexes

open access: yes, 2010
Large-bite bisphosphite ligand 1,3-C(6)H(4){OPOC(10)H(6)(mu-S)C(10)H(6)O}(2) (3), is obtained by reacting chlorophosphonite {OC(10)H(6)(mu-S)C(10)H(6)O}PCl (2) with resorcinol in the presence of triethylamine.
KUMAR, P   +7 more
core   +1 more source

Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry

open access: yesFEBS Letters, EarlyView.
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy